Edition:
India

Dr.Reddy's Laboratories Ltd (REDY.NS)

REDY.NS on National Stock Exchange of India

2,751.30INR
22 Mar 2019
Change (% chg)

Rs-0.35 (-0.01%)
Prev Close
Rs2,751.65
Open
Rs2,779.00
Day's High
Rs2,779.00
Day's Low
Rs2,738.50
Volume
685,401
Avg. Vol
981,878
52-wk High
Rs2,878.00
52-wk Low
Rs1,872.95

Select another date:

Mon, Feb 18 2019

BUZZ-India's Dr.Reddy's gains most in nearly 13 weeks after U.S FDA report

** Shares of Indian drugmaker Dr.Reddy's Laboratories Ltd climbs as much as 4.9 pct to 2,689.65 rupees, in their biggest intraday pct gain since Nov. 11

BUZZ-India's Dr.Reddy's posts sharpest intraday loss in over 17 yrs

** Shares of Indian drugmaker Dr.Reddy's Laboratories Ltd plunge as much as 29.78 pct to 1,872.95 rupees, in their biggest intraday pct loss since Oct 15, 2001

BUZZ-India's Dr.Reddy's hits near 23-mth high; chart suggests more upside

** Shares of Dr.Reddy's Laboratories Ltd gain as much as 3.11 pct to 2,878 rupees, highest since March 7, 2017

Dr. Reddy's third-quarter profit surges on strong growth in emerging markets

Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 65.3 percent surge in quarterly profit on Friday, handily beating market expectations, helped by strong growth in emerging markets.

UPDATE 1-Indian drugmaker Dr. Reddy's Q3 profit surges on strong growth in emerging markets

Feb 1 Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 65.3 percent surge in quarterly profit on Friday, handily beating market expectations, helped by strong growth in emerging markets.

Indian drugmaker Dr. Reddy's Q3 profit rises 65.3 pct, beats estimates

Feb 1 Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted a 65.3 percent surge in quarterly profit on Friday, driven by strong growth in emerging markets.

BUZZ-India's Dr.Reddy's tumbles after U.S. court puts Suboxone copy sale on hold

** Dr.Reddy's Laboratories Ltd shares fall as much as 6.7 pct to 2,534.1 rupees, their lowest since Nov 26

Dr. Reddy's shares spike after favourable generic drug ruling

Shares of Indian drugmaker Dr. Reddy's Laboratories Ltd jumped nearly 9 percent on Wednesday, their sharpest intraday gain in a year, after a U.S. court allowed the company to sell a copycat version of Indivior Plc's opioid treatment Suboxone Film.

India's Dr. Reddy's shares spike after favourable generic drug ruling

Nov 21 Shares of Indian drugmaker Dr. Reddy's Laboratories Ltd jumped nearly 9 percent on Wednesday, their sharpest intraday gain in a year, after a U.S. court allowed the company to sell a copycat version of Indivior Plc's opioid treatment Suboxone Film.

BUZZ-India's Dr. Reddy's rises most in 1 year as U.S. court allows generic drug sale

** Dr. Reddy's Laboratories Ltd shares surge as much as 8.7 pct to 2,655 rupees, their highest since Sept. 26

Select another date: